Propeptide cleavage conditions sortilin/neurotensin receptor-3 for ligand binding

被引:167
|
作者
Petersen, CM [1 ]
Nielsen, MS [1 ]
Jacobsen, C [1 ]
Tauris, J [1 ]
Jacobsen, L [1 ]
Gliemann, J [1 ]
Moestrup, SK [1 ]
Madsen, P [1 ]
机构
[1] Aarhus Univ, Dept Med Biochem, DK-8000 Aarhus C, Denmark
来源
EMBO JOURNAL | 1999年 / 18卷 / 03期
关键词
furin; neurotensin; propeptide; RAP; sortilin;
D O I
10.1093/emboj/18.3.595
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We recently reported the isolation and sequencing of sortilin, a new putative sorting receptor that binds receptor-associated protein (RAP), The luminal N-terminus of sortilin comprises a consensus sequence for cleavage by furin, (RWRR44)-W-41, which precedes a truncation originally found in sortilin isolated from human brain. We now show that the truncation results from cellular processing. Sortilin is synthesized as a preform which, in late Golgi compartments, is converted to the mature receptor by furin-mediated cleavage of a 44 residue N-terminal propeptide, We further demonstrate that the propeptide exhibits pa-dependent high affinity binding to fully processed sortilin, that the binding is competed for by RAP and the newly discovered sortilin ligand neurotensin, and that prevention of propeptide cleavage essentially prevents binding of RAP and neurotensin. The findings evidence that the propeptide sterically hinders ligands from gaining access to overlapping binding sites in prosortilin, and that cleavage and release of the propeptide preconditions sortilin for full functional activity. Although proteolytic processing is involved in the maturation of several receptors, the described exposure of previously concealed ligand-binding sites after furin-mediated cleavage of propeptide represents a novel mechanism in receptor activation.
引用
收藏
页码:595 / 604
页数:10
相关论文
共 50 条
  • [31] Distinct subdomains of the EphA3 receptor mediate ligand binding and receptor dimerization
    Lackmann, M
    Oates, AC
    Dottori, M
    Smith, FM
    Do, C
    Power, M
    Kravets, L
    Boyd, AW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (32) : 20228 - 20237
  • [32] Impact of the Proline Residue on Ligand Binding of Neurotensin Receptor 2 (NTS2)-Selective Peptide-Peptoid Hybrids
    Held, Cornelia
    Huebner, Harald
    Kling, Ralf
    Nagel, Yvonne A.
    Wennemers, Helma
    Gmeiner, Peter
    CHEMMEDCHEM, 2013, 8 (05) : 772 - 778
  • [34] Ligand binding to the serotonin 5HT3 receptor studied with a novel fluorescent ligand
    Tairi, AP
    Hovius, R
    Pick, H
    Blasey, H
    Bernard, A
    Surprenant, A
    Lundström, K
    Vogel, H
    BIOCHEMISTRY, 1998, 37 (45) : 15850 - 15864
  • [35] Bilayer lipids modulate ligand binding to atypical chemokine receptor 3
    Eberle, Stefanie Alexandra
    Gustavsson, Martin
    STRUCTURE, 2024, 32 (08)
  • [36] Structural and mechanistic insights into VEGF receptor 3 ligand binding and activation
    Leppanen, Veli-Matti
    Tvorogov, Denis
    Kisko, Kaisa
    Prota, Andrea E.
    Jeltsch, Michael
    Anisimov, Andrey
    Markovic-Mueller, Sandra
    Stuttfeld, Edward
    Goldie, Kenneth N.
    Ballmer-Hofer, Kurt
    Alitalo, Kari
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (32) : 12960 - 12965
  • [37] Strategies to prevent cleavage of the linker region between ligand-binding repeats 4 and 5 of the LDL receptor
    Strom, Thea Bismo
    Bjune, Katrine
    Costa, Luis Teixeira
    Leren, Trond P.
    HUMAN MOLECULAR GENETICS, 2019, 28 (22) : 3734 - 3741
  • [38] Toll like receptor-3 ligand POLY-ICLC promotes the efficacy of glioma vaccines-preclinical and clinical studies
    Okada, Hideho
    JOURNAL OF GENE MEDICINE, 2008, 10 (04): : 441 - 442
  • [39] Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma
    Witte, D
    Thomas, A
    Ali, N
    Carlson, N
    Younes, M
    ANTICANCER RESEARCH, 2002, 22 (03) : 1463 - 1466
  • [40] The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis
    Heckman, Caroline A.
    Holopainen, Tanja
    Wirzenius, Maria
    Keskitalo, Salla
    Jeltsch, Michael
    Yla-Herttuala, Seppo
    Wedge, Stephen R.
    Jurgensmeier, Juliane M.
    Alitalo, Kari
    CANCER RESEARCH, 2008, 68 (12) : 4754 - 4762